Bayer Group
Consolidated Statements of Comprehensive Income

 

 

Q1 2015

 

Q1 2016

 

 

€ million

 

€ million

1

Total changes recognized outside profit or loss

Income after income taxes

 

1,340

 

1,581

of which attributable to noncontrolling interest

 

6

 

70

of which attributable to Bayer AG stockholders

 

1,334

 

1,511

Remeasurements of the net defined benefit liability for post-employment benefit plans

 

(1,205)

 

(2,563)

Income taxes

 

386

 

756

Other comprehensive income from remeasurements of the net defined benefit liability for post-employment benefit plans

 

(819)

 

(1,807)

Other comprehensive income that will not be reclassified subsequently to profit or loss

 

(819)

 

(1,807)

Changes in fair values of derivatives designated as cash flow hedges

 

(341)

 

53

Reclassified to profit or loss

 

61

 

(16)

Income taxes

 

82

 

Other comprehensive income from cash flow hedges

 

(198)

 

37

Changes in fair values of available-for-sale financial assets

 

14

 

12

Reclassified to profit or loss

 

1

 

Income taxes

 

(3)

 

(4)

Other comprehensive income from available-for-sale financial assets

 

12

 

8

Changes in exchange differences recognized on translation of operations outside the eurozone

 

1,387

 

(509)

Changes in exchange differences recognized on translation of operations outside the eurozone, relating to associates accounted for using the equity method

 

(41)

 

18

Reclassified to profit or loss

 

 

Other comprehensive income from exchange differences

 

1,346

 

(491)

Other comprehensive income that may be reclassified subsequently to profit or loss

 

1,160

 

(446)

Effects of changes in scope of consolidation

 

 

Total other comprehensive income1

 

341

 

(2,253)

of which attributable to noncontrolling interest

 

15

 

(101)

of which attributable to Bayer AG stockholders

 

326

 

(2,152)

Total comprehensive income

 

1,681

 

(672)

of which attributable to noncontrolling interest

 

21

 

(31)

of which attributable to Bayer AG stockholders

 

1,660

 

(641)